SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Popular Searches

    • Glass Pharms
    • medical
    • Medical Cannabis
    • Kanabo Calls in Administrators
    • Article
    • Cannabis Health Symposium
    • antiflamx near me abbotsford bc
    • teaching feeling scene
    • for driving licence test
    • LEADER AM

    Recent Searches

      Popular Searches

      • Glass Pharms
      • medical
      • Medical Cannabis
      • Kanabo Calls in Administrators
      • Article
      • Cannabis Health Symposium
      • antiflamx near me abbotsford bc
      • teaching feeling scene
      • for driving licence test
      • LEADER AM
      News, Opinion

      The cannabis industry must earn the trust of Canadians // BofC & Ample Organics

      By
      Jay Rosenthal

      Ample Organics‘ President and CEO John Prentice and Business of Cannabis Co-Founder and President Jay Rosenthal co-authored an article for The Globe and Mail regarding the industry’s responsibility over the coming year. The piece ran on February 13, 2018.

      As Canada heads towards the era of recreational cannabis, it is against a backdrop of headlines focused on stock prices coupled with public-health and safety concerns. The Canadian Nurses Association (CNA) has asked for additional job training for its members, and workplaces throughout Canada are concerned about if and how legal cannabis might impact their work force.

      Read the full article.  

      Jay Rosenthal

      Other featured articles

      Taima Growth Becomes Spain’s Fourth AEMPS-Licensed Medical Cannabis Cultivator

      By

      Do 10 Doctors Really Prescribe Half of England’s Medical Cannabis?

      By

      From Land to Brand: Why Cannabis’s Next Generation Is Going Asset-Light

      By

      Cannabis at an Inflexion Point: A Structural Repricing Ahead

      By

      Mounting Legal Challenges Threaten Hearing to Extend Cannabis Rescheduling to Adult Use

      By

      Other featured News articles

      Cannabis at an Inflexion Point: Why Capital Is Missing the Opportunity

      By

      Vertanical Secures Milestone FDA Breakthrough Designation for Cannabis Pain Drug Ahead of Imminent European Launch

      By

      Cannabis Europa London 2026: Key Insights, Day 2

      By

      Cannabis Europa London 2026 – Key Insights, Day 1

      By

      Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026

      By

      Share Article

      The Briefing / Newsletter

      Insights
      you don't want
      to miss.

      A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

      • Policy & regulation
      • Markets & deals
      • Clinical & science
      Subscribe free

      Related news

      Companies
      Taima Growth Becomes Spain’s Fourth AEMPS-Licensed Medical Cannabis Cultivator

      By

      Data & Analysis
      Do 10 Doctors Really Prescribe Half of England’s Medical Cannabis?

      By

      Companies
      From Land to Brand: Why Cannabis’s Next Generation Is Going Asset-Light

      By

      Markets & Stocks
      Cannabis at an Inflexion Point: A Structural Repricing Ahead

      By

      Policy & Regulation
      Mounting Legal Challenges Threaten Hearing to Extend Cannabis Rescheduling to Adult Use

      By

      Medical
      Stop Consulting, Start Implementing: South Africa’s Cannabis Industry Demands Action as Businesses Suffer

      By

      Medical
      Australian State to End Automatic Licence Loss for Medical Cannabis Drivers

      By

      Opinion
      Europe’s Medical Cannabis Market Has Grown Up, Now Its Supply Chain Needs To

      By

      CBD & Hemp
      Latest French CBD Crackdown To Be Challenged In Court

      By